REIT Report: Third time’s a charm for new Aviv REIT

After two failed IPOs, post-acute and long-term care investment firm goes public

By Murray W. Wolf

When Aviv REIT Inc. (NYSE: AVIV) previously attempted an initial public offering (IPO), things didn’t turn out too well. The first attempt in 2008 by the Chicago-based healthcare real estate investment firm was torpedoed by the economic downturn, and a second IPO attempt in 2009 fell through due to resistance from investors.

But the third time was a charm. Aviv began trading on the New York Stock Exchange March 21 and the real estate investment trust (REIT) saw its share price close that day at $22.55, up almost 13 percent from its IPO estimate of $20 per share. Five days later, March 26, the REIT announced that it had not only sold out of its planned IPO of 13.2 million shares of common stock,

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In
   

Comments are closed, but trackbacks and pingbacks are open.